Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2

Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2

Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases, and for the most cancer-related deaths. The survival pathway of Akt, its downstream effectors, the mammalian target of rapamycin (mTOR) and ribosomal protein S6 kinase (p70 S6K), and the Ras-extracellular signal-regulated...

Full description

Bibliographic Details
Main Authors: Nigel Kurgan, Evelyn Tsakiridis, Rozalia Kouvelioti, Jessy Moore, Panagiota Klentrou, Evangelia Tsiani
Format: Article
Language:English
Published: MDPI AG 2017-05-01
Series:Cancers
Subjects:
lung cancer
post-exercise serum
proliferation
survival
Akt
Erk1/2
Online Access:http://www.mdpi.com/2072-6694/9/5/46

Internet

http://www.mdpi.com/2072-6694/9/5/46

Similar Items